|
My Cart (0)
|

Welcome! Log In or Register        How to best view this site

MED-PASS:  Designing Solutions for Senior Care

 

  MED-PASS Main News/Bulletin Board

grey spacer bar

UPDATED: Policies & Procedures Manual for Hospice

This manual has been designed and written to provide a comprehensive operational template for new and existing hospice agencies. The policies and procedures in this manual are based on Medicare Hospice CoPs (Conditions of Participation) and The Joint Commission, Community Health Accreditation Program (CHAP) and Accreditation Commission for Health Care (ACHC) standards.

Posted in Hospice By MED-PASS
UPDATED: Policies & Procedures Manual for Home Health Care

Updated in July 2021, this manual provides an operational template for new start-up home care agencies looking to refresh the way they operate and home care agencies seeking Medicare certification and/or accreditation with ACHC, CHAP or The Joint Commission. The manual is updated annually to reflect standards and best practices set forth by several governing bodies. 

Posted in Home Health By MED-PASS
Now Available: Informed Consent for COVID-19 Vaccine

This two-sided form provides either employees or residents/patients with general information to help make an informed decision about being vaccinated against COVID-19.

Posted in Long-Term Care By MED-PASS
UPDATED Emergency Prep Manual

UPDATED Emergency Prep Manual

7/21/2021 10:06 AM

In a continued effort to help your agency meet CMS’ Home Health Emergency Preparedness CoPs, this manual was updated June 2021!

Posted in Home Health By MED-PASS
NEW & NOW AVAILABLE: Opioid Stewardship Toolkit

Developed in partnership with ASCP and MED-PASS, this new toolkit is a comprehensive look at the opioid crisis in America, and what pharmacists can do to positively impact patients and prescribers.

Posted in Pharmacy By MED-PASS
CMS Interim Final Rule - COVID-19 Vaccine Immunization Requirements for Residents and Staff

On May 11, 2021, CMS published an interim final rule with comment period (IFC). This rule establishes Long-Term Care (LTC) Facility Vaccine Immunization Requirements for Residents and Staff. This includes new requirements for educating residents or resident representatives and staff regarding the benefits and potential side effects associated with the COVID-19 vaccine, and offering the vaccine.

Posted in Long-Term Care By MED-PASS
CMS COVID-19 Nursing Home Visitation - REVISED

CMS COVID-19 Nursing Home Visitation- REVISED

Revised April 27, 2021, CMS issued new guidance for visitation in nursing homes during COVID-19. The guidance provides reasonable ways a nursing home can safely facilitate in-person visitation to address the psychosocial needs of residents.

"CMS is committed to continuing to take critical steps to ensure America’s healthcare facilities are prepared to respond to the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (PHE)."

Posted in Long-Term Care By MED-PASS
CDC Long-Term Care Facility Toolkit: Preparing for COVID-19 Vaccination at Your Facility

The CDC published a toolkit that provides long-term care facility administrators and clinical leadership with information and resources to help build vaccine confidence among healthcare personnel and residents.

"Receiving a COVID-19 vaccine is an important step to prevent getting sick with COVID-19 disease. The decision to get vaccinated protects more than just an individual’s health. It can also help protect coworkers, residents, families, and communities. Vaccination is an important tool to help stop the pandemic."

Posted in Long-Term Care By MED-PASS
Updated: Nursing Services Policy and Procedure Manual

Updated in December 2020 the newest update features an overhaul to the Diabetes Care section. In an effort to help your facility remain compliant to evolving concerns around the COVID-19 pandemic, the earlier update in 2020 covered revised PPE considerations and COVID-19 policies and procedures.

Posted in Heaton Resources By MED-PASS
Monoclonal Antibody Treatment in Senior Care Environment

Two investigational SARS-CoV-2 neutralizing antibody treatments, bamlanivimab and casirivimab plus imdevimab are now available through Emergency Use Authorization (EUA) from the FDA for use in eligible outpatients with mild to moderate disease who are at high risk for disease progression and/or hospitalization.Residents of skilled nursing facilities (SNFs) are ideal for these novel therapies and long-term care (LTC) pharmacies provide intravenous medications (IV) routinely in SNF environments.

Posted in Pharmacy By MED-PASS